<?xml version="1.0" encoding="UTF-8"?>
<p>It was considered to integrate the effects of both treatments to show that the essential oil and the bioactive metabolite produced a similar profile in the temporal course (
 <xref ref-type="fig" rid="molecules-25-00675-f002">Figure 2</xref>A) and in the dose–response graph (
 <xref ref-type="fig" rid="molecules-25-00675-f002">Figure 2</xref>B). A maximal number of writhes was observed in mice receiving the vehicle; this point was reached after the first 10 min of the nociceptive agent injection (
 <xref ref-type="fig" rid="molecules-25-00675-f002">Figure 2</xref>A). The 
 <italic>T. lucida</italic> essential oil (0.1, 1.0, and 10 mg/kg, i.p.) produced significant antinociceptive activity by reducing writhing behavior in a dose-dependent manner, reducing nociception (75.39%) at dosage of 10 mg/kg, i.p., in a similar fashion to β-caryophyllene at doses of 3.16 and 10 mg/kg (
 <xref ref-type="fig" rid="molecules-25-00675-f002">Figure 2</xref>A,B) (time: F
 <sub>6,222</sub> = 29.68, 
 <italic>p</italic> &lt; 0.0001; treatment: F
 <sub>6,37</sub> = 49.99, 
 <italic>p</italic> &lt; 0.0001; interaction: F
 <sub>36,222</sub> = 8.68, 
 <italic>p</italic> &lt; 0.0001). Data expressed as the AUC over a period of 30 min allowed observing the significant reduction in the nociception of the essential oil and one of its metabolites, resembling that obtained with the analgesic metamizole (80 mg/kg, i.p.) (
 <xref ref-type="fig" rid="molecules-25-00675-f002">Figure 2</xref>B) (F
 <sub>7,42</sub> = 12.52, 
 <italic>p</italic> &lt; 0.0001). 
</p>
